Deborah H. Fuller

7.4k total citations · 1 hit paper
77 papers, 4.2k citations indexed

About

Deborah H. Fuller is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Deborah H. Fuller has authored 77 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Immunology, 35 papers in Virology and 30 papers in Epidemiology. Recurrent topics in Deborah H. Fuller's work include HIV Research and Treatment (35 papers), Immunotherapy and Immune Responses (30 papers) and Immune Cell Function and Interaction (18 papers). Deborah H. Fuller is often cited by papers focused on HIV Research and Treatment (35 papers), Immunotherapy and Immune Responses (30 papers) and Immune Cell Function and Interaction (18 papers). Deborah H. Fuller collaborates with scholars based in United States, United Kingdom and Cyprus. Deborah H. Fuller's co-authors include Joel R. Haynes, Harriet L. Robinson, Ellen F. Fynan, Robert G. Webster, J C Santoro, Michael D. Eisenbraun, James T. Fuller, Connie S. Schmaljohn, Dennis E. McCabe and Tamera M. Pertmer and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Deborah H. Fuller

76 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

1993 901 citations Deborah H. Fuller, Joel R. Haynes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah H. Fuller United States	31	2.3k	1.4k	1.4k	1.2k	1.2k	77	4.2k
Shixia Wang United States	37	1.9k 0.8×	1.4k 1.0×	1.0k 0.8×	1.2k 1.0×	1.2k 1.0×	138	4.2k
Joel R. Haynes United States	37	2.4k 1.0×	1.9k 1.3×	1.4k 1.1×	880 0.7×	1.2k 1.0×	60	4.9k
Michael A. Chattergoon United States	30	2.3k 1.0×	1.3k 0.9×	899 0.7×	986 0.8×	719 0.6×	58	3.8k
Susan W. Barnett United States	42	2.8k 1.2×	1.9k 1.4×	1.5k 1.1×	2.8k 2.4×	1.7k 1.4×	124	5.8k
Bryce Chackerian United States	34	1.3k 0.6×	1.4k 1.0×	1.2k 0.9×	828 0.7×	833 0.7×	87	4.2k
Jorma Hinkula Sweden	38	2.3k 1.0×	1.3k 0.9×	1.1k 0.8×	2.4k 2.0×	1.3k 1.1×	162	4.5k
Tomáš Hanke United Kingdom	38	2.9k 1.2×	2.0k 1.4×	1.5k 1.1×	3.0k 2.5×	1.2k 1.1×	139	5.4k
Helen C. Perry United States	23	1.9k 0.8×	1.4k 1.0×	1.7k 1.3×	619 0.5×	830 0.7×	27	4.2k
Niranjan Y. Sardesai United States	36	1.6k 0.7×	1.2k 0.8×	966 0.7×	626 0.5×	1.0k 0.9×	120	3.9k
Jean Boyer United States	46	4.7k 2.0×	2.4k 1.7×	2.0k 1.5×	2.2k 1.9×	1.3k 1.1×	140	7.5k

Countries citing papers authored by Deborah H. Fuller

Since Specialization

Citations

This map shows the geographic impact of Deborah H. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah H. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah H. Fuller more than expected).

Fields of papers citing papers by Deborah H. Fuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah H. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah H. Fuller. The network helps show where Deborah H. Fuller may publish in the future.

Co-authorship network of co-authors of Deborah H. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah H. Fuller. A scholar is included among the top collaborators of Deborah H. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah H. Fuller. Deborah H. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tisoncik-Go, Jennifer, Thomas B. Lewis, Leanne S. Whitmore, et al.. (2025). Persistent innate immune dysfunction and ZIKV replication in the gastrointestinal tract during SIV infection in pigtail macaques. Frontiers in Immunology. 16. 1535807–1535807.

Waalkes, Adam, Kaitlin Sawatzki, Linhui Hao, et al.. (2025). SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolution. Frontiers in Immunology. 16. 1587688–1587688. 1 indexed citations

Tisoncik-Go, Jennifer, Thomas B. Lewis, Antonio E. Muruato, et al.. (2023). Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina. SHILAP Revista de lepidopterología. 3. 2 indexed citations

Lippy, Adriana, Brian G. Oliver, James T. Fuller, et al.. (2021). Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques. PLoS Pathogens. 17(5). e1009575–e1009575. 5 indexed citations

O’Connor, Megan A., Thomas B. Lewis, Debbie Bratt, et al.. (2018). Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques. AIDS Research and Human Retroviruses. 35(3). 295–305. 9 indexed citations

Hessell, Ann J., Delphine C. Malherbe, Franco Pissani, et al.. (2016). Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens. The Journal of Immunology. 196(7). 3064–3078. 34 indexed citations

McBurney, Sean P., Sarah Gabriël, Jeremy Huynh, et al.. (2016). Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates. Vaccine. 34(30). 3500–3507. 25 indexed citations

Cui, Xinle, Goutam Sen, Gouri Chattopadhyay, et al.. (2013). A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine. Vaccine. 31(30). 3039–3045. 48 indexed citations

Palermo, Robert E. & Deborah H. Fuller. (2012). ‘Omics Investigations of HIV and SIV Pathogenesis and Innate Immunity. Current topics in microbiology and immunology. 363. 87–116. 2 indexed citations

10.

Vojnov, Lara, Alexander T. Bean, Eric Peterson, et al.. (2011). DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4+ T cells, but few subdominant epitope-specific CD8+ T cells. Vaccine. 29(43). 7483–7490. 6 indexed citations

11.

Loudon, Peter T., Eric J. Yager, Amithi Narendran, et al.. (2010). GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates. PLoS ONE. 5(6). e11021–e11021. 60 indexed citations

12.

Fuller, Deborah H., Tim Shipley, Todd M. Allen, et al.. (2007). Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques. Virology. 364(2). 245–255. 14 indexed citations

13.

Fuller, Deborah H., Premeela A. Rajakumar, Mary S. Wu, et al.. (2006). DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued. Virology. 348(1). 200–215. 30 indexed citations

14.

Fuller, Deborah H., Peter T. Loudon, & Connie S. Schmaljohn. (2006). Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods. 40(1). 86–97. 117 indexed citations

15.

Roberts, Lee K., et al.. (2005). Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine. 23(40). 4867–4878. 38 indexed citations

16.

Vogel, Thorsten U., Helen Horton, Deborah H. Fuller, et al.. (2002). Differences Between T Cell Epitopes Recognized After Immunization and After Infection. The Journal of Immunology. 169(8). 4511–4521. 30 indexed citations

17.

Allen, Todd M., Thorsten U. Vogel, Deborah H. Fuller, et al.. (2000). Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen. The Journal of Immunology. 164(9). 4968–4978. 213 indexed citations

18.

VanderZanden, L., Mike Bray, Deborah H. Fuller, et al.. (1998). DNA Vaccines Expressing either the GP or NP Genes of Ebola Virus Protect Mice from Lethal Challenge. Virology. 246(1). 134–144. 138 indexed citations

19.

Lu, Shan, Joseph C. Santoro, Deborah H. Fuller, Joel R. Haynes, & Harriet L. Robinson. (1995). Use of DNAs Expressing HIV-1 Env and Noninfectious HIV-1 Particles to Raise Antibody Responses in Mice. Virology. 209(1). 147–154. 129 indexed citations

20.

Fuller, Deborah H. & Joel R. Haynes. (1994). A Qualitative Progression in HIV Type 1 Glycoprotein 120-Specific Cytotoxic Cellular and Humoral Immune Responses in Mice Receiving a DNA-Based Glycoprotein 120 Vaccine. AIDS Research and Human Retroviruses. 10(11). 1433–1441. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact